
YC W23
Miracle
Accelerate clinical trials with real-time, actionable insights
About
Miracle is the control room for clinical trials. Our platform consolidates data from multiple trial systems into real-time dashboards, delivering automated insights that empower clinical-stage biopharmaceutical companies to streamline operations, reduce manual workflows, and accelerate data-driven decision-making. By transforming complex trial data into actionable insights, Miracle helps biopharma teams speed up clinical trials, and ultimately, improve patient outcomes.
Founder
- Jin Kim
Family Office Investors
Altss tracks family office allocations to YC-backed companies. Request access to see which family offices have invested in Miracle.
See family office activityIndustry & Focus
HealthcareDrug Discovery and DeliverySaaSB2BBiotech